Related Experiment Video
Updated: Jul 8, 2025
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Timing and treatment strategies according to SCAI classification in cardiogenic shock
Giuseppe Tarantini1, Giulia Masiero1, Holger Thiele2
1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
Insights
Timely diagnosis and treatment are crucial for cardiogenic shock (CS) patients, especially those with acute myocardial infarction (AMI). Temporary mechanical circulatory support (tMCS) can aid recovery, but optimal timing strategies for diverse CS patient populations require further study.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Devices
Background:
- Cardiogenic shock (CS) following acute myocardial infarction (AMI) is a life-threatening condition.
- Early intervention is vital to prevent severe haemo-metabolic compromise.
- Temporary mechanical circulatory support (tMCS) offers a potential therapeutic option.
Purpose of the Study:
- To summarize the current evidence on the role of timing in managing CS patients.
- To highlight knowledge gaps concerning tMCS application in AMI-CS.
- To discuss optimal treatment strategies for a heterogeneous CS population.
Main Methods:
- Review of the latest scientific evidence.
- Analysis of treatment strategies for CS and AMI-CS.
- Discussion of tMCS device applicability and timing.
Main Results:
- Timely diagnosis and intervention are critical for preventing haemo-metabolic compromise in CS.
- tMCS shows promise in supporting revascularization and recovery in AMI-CS.
- Optimization of treatment timing is essential for effective tMCS use in diverse CS patients.
Conclusions:
- The timing of interventions significantly impacts outcomes in CS patients.
- Further research is needed to optimize the timing of tMCS for various CS patient profiles.
- A tailored approach to treatment timing is crucial for improving patient recovery.
Abstract:
In patients with cardiogenic shock (CS), particularly those with acute myocardial infarction (AMI), evidence suggests that timely diagnosis and treatment interventions are critical in the prevention of haemo-metabolic compromise. Temporary mechanical circulatory support (tMCS) has shown potential in facilitating revascularization and recovery of patients with acute myocardial infarction cardiogenic shock (AMI-CS). Timing of treatment strategies for CS patients needs to be optimized for use of tMCS devices that are applicable to this heterogeneous patient population. Here, the latest evidence as well as the gaps in knowledge surrounding the role of time in the management of patients with CS is summarized.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications